Publication

1. Khan A, Gajendra S, Singh VK, Thakral D, Bakhshi S, Gupta R et al. Single cell transcriptomics derived combinatorial markers distinguished leukemic stem cells from hematopoietic stem cells in acute myeloid leukemia. Leuk Res. 2026 Feb;161:108170. doi: 10.1016/j.leukres.2026.108170. Epub 2026 Jan 21. PMID: 41579489.

2. Mendiratta M, Pandey P, Pandey S, Rai S, Mendiratta M, Gupta R, et al. Cytokine Signatures Outperform Immune Subsets in Machine Learning Models for Predicting Acute Graft-Versus-Host Disease at Neutrophil Engraftment. J Immunol Res. 2026;2026(1):e1066614. doi: 10.1155/jimr/1066614. PMID: 41811840.

3. Gupta SK, Leons GK, Sharma P, Rani L, Bakhshi S, Gupta R, et al. Application of Targeted RNA-Sequencing in High-Risk B-Cell Acute Lymphoblastic Leukemia (B-ALL): Identifying Fusions, IKZF1 Deletions, and CRLF2 Expression in an Indian Cohort. Int J Lab Hematol. 2026 Feb;48(1):117-129. doi: 10.1111/ijlh.14551. Epub 2025 Sep 3. PMID: 40899517.

4. Pant H, Gogia A, Sharma A, Wig N, Raju Sagiraju HK, Gupta R, et al. Impact of Rituximab Maintenance on outcomes in Follicular Lymphoma: An indian experience. Leuk Res Rep. 2025 Nov 29;25:100554. doi: 10.1016/j.lrr.2025.100554. PMID: 41438197; PMCID: PMC12721316.

5. Kumar L, Chethan R, Singh Malik P, Pramanik R, Sahoo R, Gupta R, et al. Characteristics of long term survivors of multiple myeloma after autologous stem cell transplantation: a retrospective analysis from a tertiary care centre in India. Lancet Reg Health Southeast Asia. 2025 Oct 27;42:100680. doi: 10.1016/j.lansea.2025.100680. PMID: 41216175; PMCID: PMC12597296.

6. Reddy LR, Kumar L, Malik PS, Sahoo RK, Prasad C, Gupta R. Management of Relapsed/Refractory Myeloma in Resource Constrained Setting: Median age (years)Age (Years)Immunoglobulin subtypeHb (G/dL)Serum creatinineeGFR mL/minuteSerum albumin (g/dL) Serum LDHPlatelets countsCirculating plasma cells CytogeneticsHypercalcemiaCo-morbiditiesDiabetesHypertensionHypothyroidismF/H of malignancy. Clin Lymphoma Myeloma Leuk. 2025 Nov;25(11):e950-e960. doi: 10.1016/j.clml.2025.07.007. Epub 2025 Jul 21. PMID: 40835537.

7. Vig M, Kumar L, Dubey S, Gupta R. Altered dynamics of T cell subsets in peripheral blood impacts disease progression in newly diagnosed multiple myeloma. Biochem Biophys Rep. 2025 Jun 23;43:102104. doi: 10.1016/j.bbrep.2025.102104. PMID: 40641743; PMCID: PMC12242439.

8. Mendiratta M, Mendiratta M, Mohanty S, Rai S, Gupta R, Dadhwal V, et al. Dose-response immunomodulatory effects of Mesenchymal stem cell-derived culture-conditioned media in acute Graft-versus-Host Disease. Regen Ther. 2025 Oct 8;30:868-874. doi: 10.1016/j.reth.2025.10.001. PMID: 41142453; PMCID: PMC12546888.

9. Gupta A, Hooda R, Motwani S, Sagar D, Aggarwal P, Gupta R, et al. MuSARCyto: Multi-Head Self-Attention-Based Representation Learning for Unsupervised Clustering of Cytometry Data. Cytometry A. 2025 Aug;107(8):551-567. doi: 10.1002/cyto.a.24956. Epub 2025 Aug 11. PMID: 40785593.

10. Singh N, Sethi A, Rani L, Saini M, Gupta R, Malhotra N, et al. Role of Non-invasive Preimplantation Genetic Testing-Aneuploidy Using Spent Culture Media and its Concordance with Trophectoderm Biopsy: A Proof of Concept and Validation Study. J Hum Reprod Sci. 2025 Apr-Jun;18(2):70-79. doi: 10.4103/jhrs.jhrs_192_24. Epub 2025 Jun 28. PMID: 40740625; PMCID: PMC12306720.

11. Ruhela V, Gupta R, Oberoi R, Gupta A. A comprehensive targeted panel of 295 genes: Unveiling key disease initiating and transformative biomarkers in multiple myeloma. Comput Biol Med. 2025 Sep;196(Pt A):110619. doi: 10.1016/j.compbiomed.2025.110619. Epub 2025 Jul 6. PMID: 40617081.

12. Singh N, Sethi A, Gupta R, Rani L, Saini M. Spotlight on the Artifacts in Next-Generation Sequencing in PGT-A: Reason for High Mosaicism Reporting. JBRA Assist Reprod. 2025 Sep 22;29(3):548-551. doi: 10.5935/1518-0557.20250018. PMID: 40674554; PMCID: PMC12469320.

13. Mendiratta M, Mendiratta M, Mohanty S, Prakash H, Malhotra L,  Gupta R, et al. Hypoxia-induced metabolic and apoptotic reprogramming enhances immunomodulation in Wharton’s jelly mesenchymal stem cells. Open access. April 17, 2026, Volume 29, Issue 4, 115363

14. Sharma P, Leons GK, Singh V, Naseer S, Ribeyron L, Bakhshi S, Gupta R, Gajendra S, Thoudam DS, Sarawat SK, Khan MA, Pushpam D, Sahoo RK, Roy A, Gupta SK*. Gene expression signature of IKZF1 deleted B-cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4. Br J Haematol. 2025 Oct;207(4):1259-1270. doi: 10.1111/bjh.70014. Epub 2025 Aug 28. PMID: 40878232.

15. Gupta SK*, Leons GK. Genetics of B-Cell Acute Lymphoblastic Leukemia (B-ALL): Recent Updates and Indian Perspective. Indian J Hematol Blood Transfus. 2025 Jul;41(3):460-477. https://doi.org/10.1007/s12288-025-01988-y

16. Wilson C, Gaur A, Swaroop P, Vishwas V, Kumar S, Ghose S, Chopra A, Sharma DN, Bakhshi S, Sharawat SK. Non-coding RNA regulation of the radiation-induced DNA damage response and its translational relevance. Discov Oncol. 2026;17(1):588. 

17. Agarwal N, Sharma U, Shree A, Kumar RR, Gorain JK, Vishwas V, Jahan F, Singh A, Palanichamy JK, Pushpam D, Bakhshi R, Chopra A, Sahoo RK, Batra A, Sharawat SK, Bakhshi S. Pleiotropic regulation of mitochondrial translational factors in governing proliferation, apoptosis and metastasis during cancer progression. World J Clin Oncol. 2026;17:113600. 

18. Kumar RR, Sharma U, Shree A, Chaudhary S, Ganguly S, Bakhshi R, Singh A, Palanichamy JK, Sahoo RK, Batra A, Sharawat SK, Pushpam D, Chopra A, Sasi A, Bakhshi S. Mitophagy-driven prognosis in pediatric acute myeloid leukemia: a new frontier. Sci Rep. 2026;16:11920. 

19. Naik A, Kataria B, Sharma V, Sharma A, Batra A, Bhatia K, Singh B, Chopra A, Rout D, Sagiraju H, Talukdar R, Tiwari S, Kumar A. Venetoclax with intensive induction chemotherapy in newly diagnosed adult acute myeloid leukemia: early outcomes from a real-world experience. Haematologica. 2025 (in press) 

20. Nakra T, Jassim M, Yadav R, Agarwala S, Das P, Nilima N, Sreenivas V, Chopra A, Dattagupta S, Iyer VK. Study of WNT and NOTCH Signaling Pathways in Hepatoblastoma: Role in Diagnosis and Prognosis. Int J Surg Pathol. 2025:10668969251346938 

21. Gogoi MP, Das P, Das N, Das S, Narula G, Trehan A, Bakhshi S, Radhakrishnan V, Seth R, Tembhare P, Singh Sachdeva MU, Chopra A, Sundersingh S, Parihar M, Bhattacharya R, Banavali S, Saha V, Krishnan S. Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India. Lancet Reg Health Southeast Asia. 2025;37:100593.  

22. Saluja S, Ganguly S, Singh J, Jain A, Sharma G, Chaudhary S, Pethusamy K, Chattopadhyay P, Chopra A, Singh A, Karmakar S, Bakhshi S, Palanichamy JK. Aberrant overexpression of m6A writer and reader genes in pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL). Transl Oncol. 2025;56:102403. 

23. Haldorai M, Meena JP, Gupta AK, Pandey RM, Chopra A, Seth R. Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy: A Randomized Controlled Trial. Am J Clin Oncol. 2025;48:421-427..

24. Sisodiya S, Singh P, Joshi T, Khan A, Mishra N, Kumar S, Tanwar P, Agrawal U, Hussain S. Differential roles of SALL transcription factors in breast cancer: Potential biomarkers. Comput Biol Med. 2026 May 1;207:111604. doi: 10.1016/j.compbiomed.2026.111604. Epub 2026 Mar 25. PMID: 41886924.

25. Baskarane H, Divakar MK, Santhosh AP, Pallavi K, Hooda V, Yenamandra VK, Kumar S, Shetty V, Banotra J, Gupta I, Minocha S, Tanwar P, Sharma A, Vasudeva P, Kumar A, Chethan R, Bakhshi S, Batra A. DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH study. Front Pharmacol. 2026 Feb 20;17:1732128. doi: 10.3389/fphar.2026.1732128. PMID: 41800094; PMCID: PMC12963234.

26. Aftab M, Shagufta, Sisodiya S, Khan A, Kumar S, Tanwar P, Hussain S. Repurposing Lapatinib and Tucatinib as Dual Inhibitors of Bcl-2 and TYMS in Breast Cancer: Insights from Transcriptomic, Computational and Cellular Assays. Appl Biochem Biotechnol. 2026 Mar 7. doi: 10.1007/s12010-026-05618-9. Epub ahead of print. PMID: 41793646.

27. Singh N, Raj Jalagam V, Somagattu S, Kunwar S, Tanwar P. Role of Training Paramedical Staff for Cervical Cancer Screening via Human Papillomavirus Self-Sampling in Remote Mountainous Regions: A Pilot Feasibility Study. Cureus. 2026 Jan 22;18(1):e102046. doi: 10.7759/cureus.102046. PMID: 41728465; PMCID: PMC12924082.

28. Singh N, Mangal S, Tanwar P, Singhal S, Yadav A, Mathur S. Evaluating The Feasibility and Acceptability of Cervical Cancer Screening in an Urban Slum Community by HPV Self-Sampling With the Aid of Telecounselling: Lessons Learnt. Asian Pac J Cancer Prev. 2025 Dec 1;26(12):4331-4338. doi: 10.31557/APJCP.2025.26.12.4331. PMID: 41459847.

29. Joseph GT, Swain SK, Somwanshi T, Singh A, Kaur M, Kamal R, Dhanda H, Kumar P, Kaushik U, Noor B, Sharma S, Tanwar P, Zaheer S, Chaudhry S, Prabhakar P, Singh A, Rishi B, Misra A. Validation of diagnostic screening test for pharmacogenomic targets for thiopurine drugs in indian pediatric acute lymphoblastic leukemia patients. Front Pharmacol. 2025 Dec 8;16:1714797. doi: 10.3389/fphar.2025.1714797. PMID: 41446785; PMCID: PMC12722899.

30. Sisodiya S, Singh P, Joshi T, Aftab M, Firdausi N, Khan A, Mishra N, Jamil Khan N, Tanwar P, Gupta V, Hussain S. Human papillomavirus-mediated cervical cancer: epigenetic interplay and clinical implications. Front Microbiol. 2025 Oct 2;16:1633283. doi: 10.3389/fmicb.2025.1633283. PMID: 41113635; PMCID: PMC12528195.

 

31. Nagpal C, Divakar MK, Baskarane H, Tansir G, Jain R, Sharma A, Sahoo RK, Bakhshi S, Gupta I, Minocha S, Kumar S, Tanwar P, Nayak B, Nayyar R, P S, Kaushal S, Ojha S, Nangla P, Haresh KP, Seth A, Batra A. Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North India. JCO Glob Oncol. 2025 Jul;11:e2500137. doi: 10.1200/GO-25-00137. Epub 2025 Jul 11. PMID: 40644643.

32. Khan A, Sisodiya S, Aftab M, Tanwar P, Hussain S, Gupta V. Mechanisms and Therapeutic Strategies for Endocrine Resistance in Breast Cancer: A Comprehensive Review and Meta-Analysis. Cancers (Basel). 2025 May 14;17(10):1653. doi: 10.3390/cancers17101653. PMID: 40427153; PMCID:PMC12109706.

33. Surabhi Jain , Sudhir Gupta , Abilash Srinivasa Murthy , Shivangi Dagar , Amar Ranjan , et al. Burden of sudden death in young adults: A one-year observational study at a tertiary care centre in India, Indian J Med Res 162, October 2025, pp 453-459 DOI: 10.25259/IJMR_938_2025

34. Gajendra Smeeta, Rani L, Kaur G, Kumar L, Sharma A, Gogia A, Gupta R. Genomic Alterations in Multiple Myeloma: A Comprehensive Landscape. Indian J Hematol Blood Transfus (2025).

35. Gupta L, Gajendra Smeeta, Jha AK, Talasila NBK.Acute Erythroid Leukemia in a Child: Insights from a Rare Case. Am J Blood Res. 2025 Aug 15;15(4):96-101. doi: 10.62347/GCUG1405. PMID: 40995195.

36. Sharma, P., Leons, G. K., Singh, V., Naseer, S., Ribeyron, L., Bakhshi, S., ... & Gupta, S. K. (2025). Gene expression signature of IKZF1 deleted B‐cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4. British Journal of Haematology, 207(4), 1259-1270.

37. Khan A, Gajendra S, Singh VK, Thakral D, Bakhshi S, Gupta Ret al. Single cell transcriptomics derived combinatorial markers distinguished leukemic stem cells from hematopoietic stem cells in acute myeloid leukemia. Leuk Res. 2026 Feb;161:108170. doi: 10.1016/j.leukres.2026.108170. Epub 2026 Jan 21. PMID: 41579489.

38. Yadav A, Kirdat K, Thorat V, Tuikhar N, et al. Description of high-altitude, cold-adaptive, metabolically versatile Dyadobacter aurulentus sp. nov. isolated from Western Himalayan farmland soils. Microbiol Spectr. 2025 Nov 4;13(11): e0114525

 

2024-2025

1. Dwivedi T, Raj A, Das N, Gupta R, Bhatnagar S, Mohan A, et al. Persistence of SARS-CoV-2 Antibodies for a Year Following SARS-CoV-2 Vaccinations (BBV152 and ChAdOx1 nCoV-19). Indian J Clin Biochem. 2025;40(1):111-120.

2. Das N, Panda D, Gajendra S, Gupta R, Thakral D, Kaur G, et al. Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity. Int J Lab Hematol. 2024 Aug;46(4):646-656.

3. Das N, Gajendra S, Gupta R. Analytical Appraisal of Hematogones in B-ALL MRD Assessment Using Multidimensional Dot-Plots by Multiparametric Flow Cytometry: A Critical Review and Update. Indian J Hematol Blood Transfus. 2024 Jan;40(1):12-24.

4. Pramanik R, Chitikela S, Deo SVS, Gogia A, Batra A, Gupta R, et al. Comprehensive germline profiling of patients with breast cancer: initial experience from a Familial Cancer Clinic. Ecancermedicalscience. 2024 Feb 15;18:1670.

5. Mendiratta M, Mendiratta M, Ganguly S, Rai S, Gupta R, Kumar L, et al. Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model. Stem Cell Res Ther. 2024 Oct 29;15(1):381.

6. Sarma R, Gupta N, Gupta A, Kumar V, Mishra S, Gupta R, et al. Effect of Opioid-Free General Anesthesia Versus Opioid-Based General Anesthesia on Postoperative Pain and Immune Response in Patients Undergoing Breast Cancer Surgery: A Randomized Controlled Trial. Indian J Surg Oncol. 2024 Dec;15(4):901-908.

7. Sagar D, Dwivedi T, Gupta A, Aggarwal P, Bhatnagar S, Gupta R et al. Clinical Features Predicting COVID-19 Severity Risk at the Time of Hospitalization. Cureus. 2024 Mar 31;16(3):e57336.

8. Singh UB, Deb S, Rani L, Gupta R, Verma S, Kumari L, et al. Phylogeny and evolution of SARS-CoV-2 during Delta and Omicron variant waves in India. J Biomol Struct Dyn. 2024 Jun;42(9):4769-4781.

9. Kumar S, Sharma A, Bakhshi S, Pushpam D, Gogia A, Gupta R, et al. Autologous Stem Cell Transplantation in Adult Hodgkin Lymphoma at a Tertiary Care Center in India: Analysis of Outcomes and Prognostic Factors. Indian J Hematol Blood Transfus. 2024 Apr;40(2):181-189.

10. Ma J, Xie R, Ayyadhury S, Ge C, Gupta A, Gupta R, et al. The multimodality cell segmentation challenge: toward universal solutions. Nature methods. 2024, 21, 6, 1103-1113.

11. Das N, Gupta R. Risk stratification in multiple myeloma–A review and update. Annals of the National Academy of Medical Sciences (India). 2024, 60, 2, 120-130.

12. Gupta SK, Leons GK. Genetics of B-Cell Acute Lymphoblastic Leukemia (B-ALL): Recent Updates and Indian Perspective. Indian J Hematol Blood Transfus, 2025. Published online 24 February 2025. https://doi.org/10.1007/s12288-025-01988-y

13. Gupta SK, Sharma S. Chronic Myeloid Leukemia in Resource Limited Settings: Treatment Free Remission and Tyrosine Kinase Resistance. Indian J Hematol Blood Transfus. 2024 Oct;40(4):555-557. doi: 10.1007/s12288-024-01899-4. Epub 2024 Oct 4. PMID: 39469169.

14. Ramani M, Singh RK, Shrivastva S, Ribeyron L, Gupta SK, Roy A. A pre-B acute lymphoblastic leukemia cell line model reveals the mechanism of thalidomide therapy-related B-cell leukemogenesis. J Biol Chem. 2024 Aug;300(8):107578. doi: 10.1016/j.jbc.2024.107578. Epub 2024 Jul 17. PMID: 39029626.

15. Sarma R, Gupta N, Gupta A, Kumar V, Mishra S, Bharati SJ, Garg R, Gupta R, Gupta SK, Deo SVS, Kumar R, Bhatnagar S. Effect of Opioid-Free General Anesthesia Versus Opioid-Based General Anesthesia on Postoperative Pain and Immune Response in Patients Undergoing Breast Cancer Surgery: A Randomized Controlled Trial. Indian J Surg Oncol 15, 901–908 (2024). https://doi.org/10.1007/s13193-024-02012-x

16. Ali MS, Hadda V, Verma S, Chopra A, Mittal S, Madan K, et al. Unravelling the transcriptomic characteristics of bronchoalveolar lavage in post-covid pulmonary fibrosis. BMC Med Genomics. 2025;18:54. 

17. Naz F, Tanveer N, Verma H, Arava S, Kakkar A, Pandey S, et al. Histomorphology based prediction of p16 immunopositivity and p16/HPV DNA co-positivity in oral squamous cell carcinoma. Ann Diagn Pathol. 2024;73:152389.

18. Rawal N, Hariprasad G, Bandyopadhyay S, Ranjan Dash N, Kumar S, Das P, et al. Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach. Biomol Biomed. 2024;25:115-143. 

19. Kumar R, Awasthi S, Pradhan D, Kumar R, Goel H, Singh J, et al. Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing. Sci Rep. 2024;14:18679.

20. Ningombam A, Verma D, Kumar R, Singh J, Ali MS, Pandey AK, et al. Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 Expression. Asian Pac J Cancer Prev. 2024;25:2283-2289.

21. Balasubramanian P, Singh J, Ranjan A, Tanwar P, Bakhshi S, Chopra A*. Flow Cytometry-Based Detection of Minimal/Measurable Residual Disease Predicts Survival Outcomes in Pediatrics, Adolescents, and Young Adults With T-acute Lymphoblastic Leukemia. Cureus. 2024;16:e61705.

22. Verma D, Kapoor S, Kumari S, Sharma D, Singh J, Benjamin M, et al. Decoding the genetic symphony: Profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights. PNAS Nexus. 2024;3:pgae01.

23. Wilson C, Swaroop P, Kumar S, Chopra A, Sharawat SK. Molecular leveraging of HOX-embedded non-coding RNAs in the progression of acute myeloid leukemia. Hum Cell. 2024;38:24.

24. Gupta L, Chopra A*. Splenic B‑cell Lymphoma / Leukemia with Prominent Nucleoli. Indian Journal of Hematology and Blood Transfusion. 2025;41:213-214.

25. Gupta L, Chopra A*. Encountering Amyloid in Bone Marrow Touch Imprints. Annals of Pathology and Laboratory Medicine. 2024;11:L3-4.

26. Gupta L, Chopra A*, Meena JP. Unveiling the rarity: a case report of TdT negative gamma delta acute lymphoblastic leukemia. Annals of Hematology and Oncology. 2024; 11:1453.

27. Arora A, Seenu V, Parshad R, Bansal VK, Dhar A, Mathur S, Tanwar P, Mishra P, Kataria K, Suhani, Gogia A, Kumar B, Haresh KP, Mallick S, Saini SK, Mishra A, Bansal B, Sharma J, Saikia J, Rangarajan K, Dhamija E, Prasad CP, Shamin SA, Agastm S, Kalra K, Vishvam D, Mani K, Kumar A, Bakhshi S, Batra A. A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC). Trials. 2025 Feb 27;26(1):73.

28. Singh R, Ramakrishna G, Sharma MK, Kumar R, Gupta E, Rastogi A, Tanwar P, Sarin SK, Trehanpati N. Droplet digital PCR technique is ultrasensitive for the quantification of covalently closed circular DNA in the blood of chronic HBV-infected patients. Clin Res Hepatol Gastroenterol. 2025 Mar;49(3):102531.

29. Tanwar P, Bhattacharya D, Dasari A, Bijwe M, Rana R, Gupta I, Minocha S. Dynamic gene expression pattern in zebrafish gallbladder: an experimental study. Int J Surg. 2024 Dec 1;110(12):7585-7589.

30. Naz F, Tanveer N, Verma H, Arava S, Kakkar A, Pandey S, Goel H, Ranjan A, Chopra A, Tanwar P. Histomorphology based prediction of p16 immunopositivity and p16/HPV DNA co-positivity in oral squamous cell carcinoma. Ann Diagn Pathol. 2024 Dec;73:152389

31. Sisodiya S, Kasherwal V, Rani J, Mishra N, Kumar S, Khan A, Aftab M, Shagufta, Singh P, Gupta E, Tanwar P, Hussain S. Impact of combinatorial immunotherapies in breast cancer: a systematic review and meta-analysis. Front Immunol. 2024 Oct 16;15:1469441.

32. Deswal M, Yadav D, Kumar V, Meenu M, Tanwar P, Srivastava S, Singh P, Sandeep K. Clinico-Pathological Factors and AR-LBD Mutations in Early and Late Castration-Resistant Prostate Cancer. Cancer Manag Res. 2024 Oct 21;16:1509-1516

33. Rawal N, Hariprasad G, Bandyopadhyay S, Ranjan Dash N, Kumar S, Das P, Dey S, Ahmad Khan M, Ranjan A, Chopra A, Saluja S, Hussain S, Rath GK, Kaur T, Tanwar P. Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach. Biomol Biomed. 2024 Dec 11;25(1):115-143.

34. Kumar R, Goel H, Solanki R, Rawat L, Tabasum S, Tanwar P, Pal S, Sabarwal A. Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy. Med Drug Discov. 2024 Sep;23:100195

35. Singh N, Tanwar P, Singhal S, Mohan T, Mittal C, Mangal S, Kaur J, Meena J, Singh A, Mathur S, Ghatage P, Bhatla N. Novel Strategy of Training the Accredited Social Health Activists via Application-Based Telemedicine for Cervical Cancer Screening by Human Papillomavirus Self-Sampling: The TRACK Study. JCO Glob Oncol. 2024 Aug;10:e2400158.

36. Awasthi S, Kumar R, Pradhan D, Rawal N, Goel H, Sahu P, Sisodiya S, Rana R, Kumar S, Dash NR, Das P, Agrawal U, Rath GK, Kaur T, Dhaliwal RS, Hussain S, Saluja SS, Tanwar P. Genomic landscape of gallbladder cancer: insights from whole exome sequencing. Int J Surg. 2024 Nov 1;110(11):6883-6897.

37. Kumar R, Awasthi S, Pradhan D, Kumar R, Goel H, Singh J, Haider I, Deo SVS, Kumar C, Srivastava A, Bhatnagar A, Kumar R, Lakshmi S, Augustine P, Ranjan A, Chopra A, Gogia A, Batra A, Mathur S, Rath GK, Kaur T, Dhaliwal RS, Mathew A, Agrawal U, Hussain S, Tanwar P. Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing. Sci Rep. 2024 Aug 12;14(1):18679.

38. Ningombam A, Verma D, Kumar R, Singh J, Ali MS, Pandey AK, Singh I, Bakhshi S, Sharma A, Pushpam D, Palanichamy JK, Tanwar P, Ranjan Singh A, Chopra A. Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 Expression. Asian Pac J Cancer Prev. 2024 Jul 1;25(7):2283-2289.

39. Rathor A, Malik PS, Tanwar P, Khurana S, Baskarane H, Pushpam D, Nambirajan A, Jain D. 'Plasma first' approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinoma. J Cancer Res Clin Oncol. 2024 Jul 27;150(7):371.

40. Balasubramanian P, Singh J, Ranjan A, Tanwar P, Bakhshi S, Chopra A. Flow Cytometry-Based Detection of Minimal/Measurable Residual Disease Predicts Survival Outcomes in Pediatrics, Adolescents, and Young Adults With T-acute Lymphoblastic Leukemia. Cureus. 2024 Jun 5;16(6):e61705.

41. Khan A, Singh D, Waidha K, Sisodiya S, Gopinath P, Hussian S, Tanwar P, Katare DP. Analysis of Inhibition Potential of Nimbin and its Analogs against NF-κB Subunits p50 and p65: A Molecular Docking and Molecular Dynamics Study. Anticancer Agents Med Chem. 2024;24(4):280-287.

42. Kumar, R., Awasthi, S., Pradhan, D. et al. Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing. Sci Rep 14, 18679 (2024). IF 3.8

43. Naz F, Tanveer N, Verma H, Arava S, Kakkar A, Pandey S, Goel H, Ranjan A, Chopra A, Tanwar P. Histomorphology based prediction of p16 immunopositivity and p16/HPV DNA co-positivity in oral squamous cell carcinoma. Ann Diagn Pathol. 2024 Dec;73:152389. doi: 10.1016/j.anndiagpath.2024.152389. Epub 2024 Oct 24. PMID: 39481322.

44. Das N, Panda D, GajendraSmeeta, Gupta R, Thakral D, Kaur G, et al. Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity. Int J Lab Hematol. 2024 Aug;46(4):646-656. doi: 10.1111/ijlh.14250.

45. Das N, Panda D, Gajendra S, Gupta R*, Thakral D, Kaur G, et al.Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity. Int J Lab Hematol. 2024. doi: 10.1111/ijlh.14250.

46. Mendiratta M, Mendiratta M, Ganguly S, Rai S, Gupta R, Kumar L, Bakhshi S, Dadhwal V, Pushpam D, Malik PS, Pramanik R, Aggarwal M, Gupta AK, Dhawan R, Seth T, Mahapatra M, Nayak B, Singh TD, Kumar S, Mir RA, Kaur G, GuruRao H, Singh M, Prasad CP, Prakash H, Mohanty S, Sahoo RK. Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model. Stem Cell Res Ther. 2024 Oct 29;15(1):381. doi: 10.1186/s13287-024-03947-2. PMID: 39468660 Free PMC article.

47. Pramanik R, Chitikela S, Deo SVS, Gogia A, .. Gupta R, Thakral D, et al. Comprehensive germline profiling of patients with breast cancer: initial experience from a Familial Cancer Clinic. Ecancermedicalscience. 2024; 18:1670. doi: 10.3332/ecancer.2024.1670.

48. Das N, Panda D, Gajendra S, Gupta R, Thakral D, Kaur G, et al. Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity. Int J Lab Hematol. 2024. doi: 10.1111/ijlh.14250.

49. Thakral D, Ramanan T, Bagri NK. CAR T-Cell Therapy: A Promising Modality for Autoimmune Diseases. Indian Pediatr. 2024;61(10):983-986.

50. Das N, Panda D, Gajendra S, Gupta R, Thakral D, Kaur G, Khan A, Singh VK, Vemprala A, Bakhshi S, Seth R. Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10‐colour panel by multiparametric flow cytometry: Dciphering the spectrum, complexity and immunophenotypic heterogeneity. International Journal of Laboratory Hematology. 2024 Mar 8.

51. Thakral, Deepshi; Chaddha, Muskan; Nimje, Megha; Singh, Vivek Kumar; Khan, Aafreen; Gupta, Ritu; Bakhshi, Sameer. Evaluation of full spectrum cell-free RNA in peripheral blood as potential biomarker for acute myeloid leukemia disease profiling. The Journal of Liquid Biopsy. 2024; Volume 5.:100226

     

 

 

 2023-2024 

1. Alam MT, Ali MS, Goel H, Singh J, Chatterjee B, Bose S, Hadda V, Chopra A. Expression Profile, Molecular Association, and Clinical Significance of POLD4 in Glioblastoma. Cell Mol Neurobiol. 2023;43:3753-3765.

   Anticancer Agents Med Chem. 2023 Sep 8. 

2. Arora M, Kumari S, Kadian L, Anupa G, Singh J, Kumar A, Verma D, Pramanik R, Kumar S, Yadav R, Chopra A, Chauhan SS. Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma. Biosci Rep. 2023;43:BSR20222472.

3. Batra G, Murugesan DR, Raghavan S, Chattopadhyay S, Mehdi F, Gupta R et al. Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting. Indian J Med Res. 2023;157(6):509-518.

4. Chaddha M, Rai H, Gupta R, Thakral D. Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment. Front Genet. 2023; 14:1138625.

5. Chatzikonstantinou T, Scarfò L, Karakatsoulis G, Minga E, Chamou D, Gupta R et al. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. EClinicalMedicine. 2023; 65:102307.

6. Chauhan R, Gupta A, Malhotra L, Bhat AA, Pandita RK, Masoodi T, Dagar G, Sadida HQ, Al-Marzooqi SK, Batra A, Bakhshi S, Sharma MC, Tanwar P, Khan SA, Samath EA, Uddin S, Akil ASA, Haris M, Macha MA, Pandita TK, Singh M. Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progression. J Transl Med. 2023 Apr 28;21(1):286. doi: 10.1186/s12967-023-04126-2. PMID: 37118828; PMCID: PMC10142227.

7. Chopra P, Sehgal T, Yadav R, Meena S, Maitra S, Gupta R et al. A Combination of Inflammatory and Hematological Markers is Strongly Associated with the Risk of Death in Both Mild and Severe Initial Disease in Unvaccinated Individuals with COVID-19 Infection. EJIFCC. 2023;34(1):42-56.

8. Choudhary S, Ganguly S, Palanichamy JK, Singh A, Pradhan D, Bakhshi R, Chopra A, Bakhshi S. Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients. Frontiers in Oncology. 2023;13:1109518. 

   Controlled Trials. J Pediatr Hematol Oncol. 2023 Oct 1;45(7):361-369. doi: 10.1097/MPH.0000000000002737. Epub 2023 Aug 3. PMID: 37539996.

 

9. Das N, Gajendra S, Gupta R. Analytical Appraisal of Hematogones in B-ALL MRD Assessment Using Multidimensional Dot-Plots by Multiparametric Flow Cytometry: A Critical Review and Update. Indian J Hematol Blood Transfus. 2024;40(1):12-24. .

10. Das N, Gupta R. Voyage of Measurable Residual Disease Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry. Indian J Med Paediatr Oncol 2023; 44(05): 515-524.

11. Das N, Panda D, Gajendra S, Gupta R, Thakral D, Kaur G, et al. Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity. Int J Lab Hematol. 2024. doi: 10.1111/ijlh.14250.

12. Dubey H, Goel H, Verma S, Gupta S, Tanwar K, Rahul E, Kapoor G, Vasantharaman J, Ranjan A, Tanwar P, Chopra A.Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population. AmericanJournalofBloodResearch 2022 Dec 15;12(6):190-195

13. Dubey H, Jain G, Kumar C, Ranjan A, Batra A, Chellapuram SK, Gupta S, Goel H, Sharma A, Tanwar P. Bone marrow metastasis of testicular germ cell tumour: A rare case. Heliyon. 2023 May 29;9(6):e16703. doi: 10.1016/j.heliyon.2023.e16703. PMID: 37303538; PMCID: PMC10248114.

14. Dubey H, Ranjan A, Durai J, Khan MA, Lakshmy R, Khurana S, Gupta S, Meena J, Ray MD, Tanwar P, Chopra A, Tiwari S. Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer.Cancer Treat Res Commun. 2023;34:100672

15. Dwivedi T, Raj A, Das N, Gupta R, Gupta N, Tiwari P et al. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study from a Tertiary Care Hospital in India. Cureus. 2023;15(6): e40273.

16. Dwivedi, T., Raj, A., Das N, Gupta R, Bhatnagar S, Mohan A et al. R Persistence of SARS-CoV-2 Antibodies for a Year Following SARS-CoV-2 Vaccinations (BBV152 and ChAdOx1 nCoV-19). Ind J Clin Biochem (2023). https://doi.org/10.1007/s12291-023-01149-w Epub 2023 Jun 14. PMID: 37327582; PMCID: PMC10285278.

17. G Kaur, Ayushi Jain, Kamaljeet Singh, Rahul Ahuja, Lingaraja Jena, Indresh Kumar Singh, Pramod Kumar Verma, Sangita Vashishtha, Vikas Bisht, Deepshi Thakral, Ranjit Kumar Sahoo, Atul Sharma, Lalit Kumar and Ritu Gupta. P1: T cell receptor beta gene diversity identified by Next Generation Sequencing in Chronic Myeloid Leukemia patients. HLA 2023;101

18. Gajendra S, Anupurba S, Gupta R, Mallick S, Panda D, Thakral D et al. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity. Int J Lab Hematol. 2023;45(4):541-552.

19. Gajendra S, Gupta R, Thakral D, Gupta SK, Jain G, Bakhshi S et al. CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations. Int J Lab Hematol. 2023; 45(2): 221-228.

20. Gajendra S, Gupta R, Thakral D, Gupta SK, Jain G, Bakhshi S, et al. CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations. Int J Lab Hematol. 2023 Apr;45(2):221-228. doi: 10.1111/ijlh.14007

21. Gajendra Smeeta, Gupta R, Thakral D, Gupta SK, Jain G, Bakhshi S, Sharma A, Sahoo RK, Kumar L, Rai S, Singh S, Upadhyay AD. CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations. Int J Lab Hematol. 2023 Apr;45(2):221-228. doi: 10.1111/ijlh.14007.

22. Gajendra Smeeta, Jha B, Sharma R. Therapy related AML in a case of chronic lymphocytic leukemia. Am J Blood Res. 2023 Apr 15;13(2):77-83.

23. Goel H, Kumar R, Tanwar P, Upadhyay TK, Khan F, Pandey P, Kang S, Moon M, Choi J, Choi M, Park MN, Kim B, Saeed M.Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemiaBiomed Pharmacother. 2023 Feb 1;160:114351

24. Gogia A, Gupta R, Sharma A, Kumar L, Rani L, Mallick S. Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients. Indian J Hematol Blood Transfus. 2023;39(1):33-39. doi: 10.1007/s12288-022-01544-y. PMID: 36699426; PMCID: PMC9868021.

25. Gomathy SB, Kakkar A, Gupta R, Elavarasi A. Myeloblastic meningeal neoplasm: an unusual natural history. BMJ Case Rep. 2024;17(1):e256821.

26. Gupta A, Gehlot S, Goswami S, Motwani S, Gupta R, Faura ÁG et al. A challenge & dataset on segmentation of Multiple Myeloma plasma cells from microscopic images. Med Image Anal. 2023; 83:102677.

27. Gupta R, Jevremovic D, Mathew SJ, Kumar S. Multiparametric Flow Cytometry in the Evaluation of Plasma Cell Proliferative Disorders: Current Paradigms for Clinical Practice. Clin Lymphoma Myeloma Leuk. 2024;24(3):e88-e95.

28. Harshita Dubey, Amar Ranjan, Anil Sharma, Swati Gupta, Khushi Tanwar, Saransh Verma, Leena Gupta, Pranay Tanwar, Anita Chopra, Arvind Kumar, Harsh Goel, Diagnostic role of TTF1 expression in a case of carcinoma of unknown primary, Am. J. Transl. Res. Accepted on March 01, 2023, IF 2.52, Cite Score 3.0

    hotspot mutation by droplet digital PCR in breast cancer among Indian population. Cancer Cell Int. 2023 Oct 11;23(1):236. 

29. Kakkar A, Satapathy S, Sikka K, Tanwar P, Deo S, Jain D. Evaluation of high- risk human papillomavirus in sinonasal papillomas and squamous cell carcinomas. Virchows Arch. 2023 Sep;483(3):381-392. doi: 10.1007/s00428-023-03601-x. Epubb 2023 Jul 15. PMID: 37452847.

30. Kante B, Vuyyuru SK, Gupta R, Dwivedi T, Kumar P, Mundhra S et al. High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India. Indian J Gastroenterol. 2023;42(1):70-78.

31. Khan A, Singh D, Waidha K, Sisodiya S, Gopinath P, Hussian S, Tanwar P, Katare DP. Analysis of Inhibition Potential of Nimbin and its Analogs against NF-κB Subunits P50 and P65: A Molecular Docking and Molecular Dynamics Study.

32. Khare A, Singh AR, Datta SK, Singh S, Gupta A, Gupta R et al. Impact of Life Cycle Costing in Procurement of Robotic Track-Based Central Laboratory at Apex Medical Institute in India. J Lab Physicians. 2023;15(4):539-544.

33. Kumar L, Sahoo RK, Kumar S, Baa AK, Tansir G, Gupta R et al; for AIIMS Myeloma Group. Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome. Leuk Lymphoma. 2023;64(2):378-387.

34. Kumar N, Tandon A, Rana R, Rana DS, Bhalla AK, Gupta R et al. Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population. Diagnostics (Basel). 2023;13(23):3540.

35. Kumar R, Kumar R, Goel H, A Gogia. SVS Deo, S Mathur Pranay Tanwar. Comprehensive mutations analyses of FTO (fat mass and obesity associated gene) and their effects on FTO's substrate binding implicated in obesity accepted in Frontier of Oncology

36. Kumar R, Kumar R, Goel H, Kumar S, Ningombam SS, Haider I, Agrawal U, Deo S, Gogia A, Batra A, Sharma A, Mathur S, Ranjan A, Chopra A, Hussain S, Tanwar P. Whole exome sequencing identifies novel variants of PIK3CA and validation of

37. Kumar S, Nadda N, Quadri A, Kumar R, Paul S, Tanwar P, Gamanagatti S, Dash NR, Saraya A, Shalimar, Nayak B. Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma. Front Genet. 2023 Aug 1;14:1235260.

38. Kumari S, Ali MS, Singh J, Arora M, Verma D, Pandey AK, Benjamin M, Bakhshi S, Palanichamy JK, Sharma A, Singh I, Tanwar P, Singh AR, Pushpam D, Qamar I, Chopra A. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia. Hematol Oncol. 2022 May 29.

39. Leons GK, Sharma P, Gupta SK, Gupta R, Rani L, Gajendra S, et al. Detection of a novel SNX2 gene breakpoint in the SNX2::ABL1 fusion transcript in Ph-like B-cell acute lymphoblastic leukemia. Pediatr Blood Cancer. 2023;70(10): e30546.

40. Ma J, Xie R, Ayyadhury S, Ge C, Gupta A, Gupta R, et al. The multimodality cell segmentation challenge: toward universal solutions. Nature Methods. 2024. doi: 10.1038/s41592-024-02233-6

41. Makkar H, Majhi RK, Goel H, Gupta AK, Chopra A, Tanwar P, Seth R. Acute myeloid leukemia: novel mutations and their clinical implications. Am J Blood Res. 2023 Feb 15;13(1):12-27. PMID: 36937458; PMCID: PMC10017594.

42. Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Gupta R et al. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia. 2023;37(2):339-347.

43. Meena JP, Gupta AK, Jat KR, Anandani G, Sasidharan A, Tanwar P. Efficacy and Safety of Olanzapine for the Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Systematic Review and Meta-analysis of Randomized

44. Mohapatra D, Gupta AK, Haldar P, Meena JP, Tanwar P, Seth R. Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis. Pediatr Hematol Oncol. 2022 May 26:1-12.

45. Mookerjee A, Gupta R, Kumar R, Sharma A, Pandey RM, Kumar L. Dual assessment with multiparameter flow cytometry and 18F-FDG PET/CT scan provides enhanced prediction of measurable residual disease after autologous haemopoietic stem cell transplant in myeloma-a prospective study. Bone Marrow Transplant. 2023;58(9):1045-1047.

46. N Naruse TK, Konishi-Takemura M, Yanagida R, Sharma G, Vajpayee M, Terunuma H, Mehra NK, Kaur G, Kimura A. Killer cell immunoglobulin-like receptor three domains long cytoplasmic tail 1 gene 007 may modulate disease progression of human immunodeficiency virus-1 infection in the Japanese population. Int J Immunogenet. 2023 Feb 17;. doi: 10.1111/iji.12617. [Epub ahead of print] PubMed PMID: 36807537

47. Natarajan J, Mathur S, Vishnubhatla S, Kumar S, Vashist S, Ramanujam N, Singhal S, Meena J, Tanwar P, Bhatla N.Can portable Colposcopes Replace Standard-of-care Colposcopes? A Crossover Trial of Two Portable Colposcopes with a Standard-of-Care Video ColposcopeAsian Pac J Cancer Prev. 2022 Dec 1;23(12):4013-4021

48. Naz F, Tanveer N, Verma H, Sudheer KA, Kakkar A, Ranjan A, Chopra A, Tanwar P. Relevance of Partial p16 Immunostaining in Oral Squamous Cell Carcinoma and Co- Relation with HPV DNA Status. Asian Pac J Cancer Prev. 2023;24:4093-4096.

49. Naz F, Tanveer N, Verma H, Sudheer KA, Kakkar A, Ranjan A, Chopra A, Tanwar P. Relevance of Partial p16 Immunostaining in Oral Squamous Cell Carcinoma and Co- Relation with HPV DNA Status. Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4093-4096.

50. Neetu Rawal, Supriya Awasthi , Nihar Ranjan Dash, Sunil Kumar, Prasenjit Das, Amar Ranjan, Anita Chopra , Maroof Ahmad Khan, Sundeep Saluja , Showket Hussain and Pranay Tanwar. Prognostic Relevance of PDL1 and CA19-9 Expression in Gallbladder Cancer vs. Inflammatory Lesions. Curr. Oncol. 2023, 30(2), 1571-1584

51. Nigombam A, Verma D, Kumar R, Ali MS, Singh J, Arora M, Singh I, Kumari S, Bakhshi S, Sharma A, Palanichamy JK, Tanwar P, Singh AR, Chopra A. Prognostic relevance of NPM1, CEBPA, and FLT3 mutations in cytogenetically normal adult AML patients. Am J Blood Res. 2023;13:28-43.

52. Nitu Kumari, Pawan Vasudeva, Pranay Tanwar, Showket Hussain, Anup Kumar, Usha Agrawal Peroxiredoxins – Urinary Surveillance Biomarkers in Urothelial Cancer. Journal of Cancer 2022, Vol. 13 2751-56

53. Pramanik R, Chitikela S, Deo SVS, Gogia A, Batra A, Gupta R et al. Comprehensive germline profiling of patients with breast cancer: initial experience from a Familial Cancer Clinic. Ecancermedicalscience. 2024;18:1670.

54. Rai S, Das N, Gupta R, Kumar L, Sharma A, Singh S et al. Utility of CD229 as novel marker in measurable residual disease assessment in multiple myeloma-An evidence-based approach. Int J Lab Hematol. 2023;45(2):179-186.

55. Rawal N, Awasthi S, Dash NR, Kumar S, Das P, Ranjan A, Chopra A, Khan MA, Saluja S, Hussain S, Tanwar P. Prognostic relevance of PDL1 and CA19-9 expression in gall bladder cancer vs inflammatory lesions. Curr Oncol. 2023;30:1571-1584.

    receptor-like factor 2 in pediatric B-lineage acute lymphoblastic leukemia. Am J Cancer Res. 2023 Jun 15;13(6):2452-2470. PMID: 37424808; PMCID: PMC10326580.

 

56. Roy RK, Yadav R, Sharma U, Wasson MK, Sharma A, Tanwar P, Jain A, Prakash H. Impact of noncoding RNAs on cancer directed immune therapies: Now then and forever. Int J Cancer. 2022 Apr 30. doi: 10.1002/ijc.34060.

57. Ruhela V, Jena L, Kaur G, Gupta R, Gupta A. BDL-SP: A Bio-inspired DL model for the identification of altered Signaling Pathways in Multiple Myeloma using WES data. Am J Cancer Res. 2023 Apr 15;13(4):1155-1187.

58. Sagar D, Dwivedi T, Gupta A, Aggarwal P, Bhatnagar S, Gupta R et al. Clinical Features Predicting COVID-19 Severity Risk at the Time of Hospitalization. Cureus 2024; 16(3): e57336.

59. Sharma G, Tran TM, Bansal I, Beg MS, Bhardwaj R, Bassi J, Tan Y, Jaiswal AK, Tso C, Jain A, Singh J, Chattopadhyay P, Singh A, Chopra A, Bakhshi S, Casero D, Rao DS, Palanichamy JK. RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia. J Exp Clin Cancer Res. 2023;42:231.

60. Singh J, Benjamin M, Pandey AK, Kumari S, Ali MS, Palanichamy JK, Bakhshi S, Singh A, Pushpam D, Kumar A, Seth R, Singh I, Tanwar P, Singh AR, Sharma G, Arora M, Chopra A. Prognostic relevance of surface expression of cytokine receptor-like factor 2 in pediatric B-lineage acute lymphoblastic leukemia. Am J Cancer Res. 2023;13:2452-2470.

61. Singh J, Benjamin M, Pandey AK, Kumari S, Ali MS, Palanichamy JK, Bakhshi S, Singh A, Pushpam D, Kumar A, Seth R, Singh I, Tanwar P, Singh AR, Sharma G, Arora M, Chopra A. Prognostic relevance of surface expression of cytokine

62. Singh UB, Deb S, Rani L, Bhardwaj D, Gupta R, Kabra M et al. Genomic surveillance of SARS-CoV-2 upsurge in India due to omicron sub-lineages BA.2.74, BA.2.75 and BA.2.76. Lancet Reg Health Southeast Asia. 2023 11:100148.

63. Sisodiya S, Kasherwal V, Khan A, Roy B, Goel A, Kumar S, Arif N, Tanwar P, Hussain S. Liquid Biopsies: Emerging role and clinical applications in solid tumours. Transl Oncol. 2023 Sep;35:101716. doi: 10.1016/j.tranon.2023.101716.

64. Sudhakaran S, Bhatla N, Mathur SR, Mahey R, Vashist S, Natarajan J, Kachhawa G, Kumari R, Tanwar P. Evaluation of cervical cancer screening during pregnancy in India: Human papillomavirus testing can change the paradigm. Natl Med J India. 2023 Jan-Feb;36(1):17-21.

65. Suri TM, Hadda V, Ali S, Chopra A, Khan MA, Singh J, Ghosh T, Mittal S, Tiwari P, Madan K, Mohan A, Guleria R. Association of Leukocyte Subpopulations Identified by Flow Cytometry with Outcomes of Sepsis in a Respiratory Intensive Care Unit: An Observational Study. J Intensive Care Med. 2024;39:125-135.

66. Thakral D, Singh VK, Gupta R, Jha N, Khan A, Kaur G et al. Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia. Ann Hematol. 2023;102(1):73-87. .

67. Vemprala A, Gajendra S, Gupta R, Thakral D, Bakhshi S, Sahoo RK, et al. Clinico-Hematological Profile of Acute Myeloid Leukemia: Experience from a Tertiary Care Cancer Center in North India. Cureus. 2023;15(12):e50869. doi: 10.7759/cureus.50869. .

68. Verma D, Kapoor S, Kumari S, Sharma D, Singh J, Benjamin M, Bakhshi S, Seth R, Nayak B, Sharma A, Pramanik R, Palanichamy JK, Sivasubbu S, Scaria V, Arora M, Kumar R, Chopra A. Decoding the genetic symphony: Profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights. PNAS Nexus. 2024;3:pgae01.

69. Verma S, Dubey H, Gupta S, Ranjan A, Goel H, Sharma A. Neuroendocrine carcinoma of cervix and review literature. Int J Surg Case Rep. 2023 Apr;105:107982. doi: 10.1016/j.ijscr.2023.107982. PMID: 36948055; PMCID: PMC10040689. IF 1.0, Online ISSN: 2210-2612

70. Vinothkumar K, Chanda S, Singh VK, Biswas S, Mohapatra S, Biswas G, Chakraborty S. EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells. International Journal of Hematology. 2023 Jan;117(1):110-20.

 

 

Publications (Last Five Years)

1. Baranwal AK, Goswami S, Bhat DK, Kaur G, Agarwal SK, Mehra NK. Soluble Major Histocompatibility Complex Class I related Chain A (sMICA) levels influence graft outcome following Renal Transplantation. Hum Immunol. 2018 Jan 9. Pii: s0198-8859 (18) 30001-6. PMID: 29330111
2. Chakraborty S, Gupta D, Thakral D, Bakhshi S, Kumar P, Kabra SK and Mitra DK. Successful reconstitution of leukocyte adhesion defect after umbilical cord blood stem cell transplant. Cent Eur J Immunol. 2018 (In print)
3. Mohanty SK, Thakral D, Gupta D, Kumar P & Mitra DK. Diminished CD40L expression on T-cells in a case of disseminated Cryptococcosis'. Indian J Pathol & Microbiol. 2018; 61(1):137-40.PMID: 29567905
4. Sharma A, Tilak T, Bakhshi S, Raina V, Kumar L, Chaudhary SP, Sahoo RK, Gupta R, Thulkar S. Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation. ESMO Open. 2017; 13;1(6):e000138, PMID: 28848667
5. Kumar L, Gogi L, Patel A, Mookerjee A, Sahoo R, Malik P, Sharma A, Thulkar S, Kumar R, Biswas A, Gupta R, Sharma OD. Multiple myeloma with Extra medullary disease: Impact of Autologous stem cell transplantation on outcome. Bone Marrow Transplantation 2017; 52:1473-1475, PMID: 28805789
6. Rani L, Mathur N, Gupta R, Gogia A, Kaur G, Dhanjal JK, Sundar D, Kumar L, Sharma A. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia. Clin Epigenetics. 2017 May 30; 9:57, PMID: 28572861.
7. Gupta R, Kumar L, Dahiya M, Mathur N, Harry P, Sharma A, Sharma OD, ShekharV.Minimal Residual Disease Evaluation in ASCT recipients with Multiple Myeloma. Leuk Lymphoma. 2017;58(5):1234-1237PMID: 27658735
8. Gupta SK, Bakhshi S, Kumar L, Kamal VK, Kumar R. Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia. Leukemia & Lymphoma, 2017; 58(2):333-342 PMID:27339065
9. Misra A, Bakhshi S, Kumar R, Chopra A. Pediatric plasmablastic lymphoma: Diagnostic and therapeutic dilemma. Indian J Pathol Microbiol. 2017;60(2):303-304,
10. Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, Bakhshi S. Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patients. LeukLymphoma. 2017; 58(7):1617-1623, PMID: 27919174.
11. Balasubramanian P, Chopra A, Verma D, Singh IK, Kumar A, Sharma A, Kumar R. Imatinib resistance in chronic myeloid leukemia due to a rare mutation. Leuk Lymphoma. 2017; 58(7):1750-1752, PMID: 27868464.
12. Kumar U, Ramteke P, Das P, Gogia A, Tanwar P. Isolated bone marrow metastasis of testicular tumor: A rare cause of thrombocytopenia. Urology Annals; 2017; 9; 96-98, PMID: 28216942.
13. Ranjan A, Ganguli P, Pathak N, Ranjan A, Thapa R, Tripathi S. Correlation of serology with morphological changes in gastric biopsy of H. pylori infection, Int. J. of Res in Med Sc. 2017, 5, 5.
14. Ray MD, Ranjan A, Bharti S, Transformation of Mature Teratoma into Adenocarcinoma in an 18-year-old Boy, Ind J. of Clin Pract, Vol. 27, No. 11, April 2017, P. 1042-44.
15. Baranwal AK, Bhat DK, Goswami S, Agarwal SK, Kaur G, Kaur J, Mehra N. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation. Indian J Med Res. 2017 Feb; 145(2):222-228.PMID:2863959916. Rani L, Mathur N, Gupta R, Gogia A, Kaur G, Dhanjal JK, Sundar D, Kumar L,Sharma A. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia. Clin Epigenetics. 2017 May 30; 9:57. PMID:2857286117. Ramsuran V, Hernández-Sanchez PG, O'hUigin C, Sharma G, Spence N, Augusto DG, Gao X, García-Sepúlveda CA, Kaur G, Mehra NK, Carrington M. Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes. J Immunol. 2017 Feb 1. pii: 1601679. doi: 10.4049/jimmunol.1601679, PMID: 28148735.18. Ramanujam B, Ihtisham K, Kaur G, Srivastava S, Mehra NK, Khanna N, Singh M, Tripathi M. Spectrum of Cutaneous Adverse Reactions to Levetiracetam and Human Leukocyte Antigen Typing in North-Indian Patients. J Epilepsy Res. 2016 Dec 31;6(2):87-92. doi: 10.14581/jer.16016. PubMed PMID: 28101480; PubMed Central PMCID: PMC5206105.
19. Singh M, Thakral D, Kar HK, Rishi N, Sharma PK & Mitra DK. Distinct clinico-immunological profile of patients infected with human papilloma virus genotypes 6 and 11. VirusDisease 2017;28 (2):200-204. PMID: 28770246
20. Singh M, Thakral D, Rishi N, Kar HK & Mitra DK. Functional characterization of CD4 and CD8 T cell responses among human papillomavirus infected patients with ano-genital warts. VirusDisease 2017; 28(2):133-140. PMID:28770238
21. Singh M, Thakral D, Rishi N, Kar HK & Indian Journal of Medical Biochemistry 2017;21(1):11-16. Mitra DK. Immune response profiling of patients with ano-genital warts.
22. Ramakrishna BS, Makharia GK, Chetri K, Dutta S, Mathur P, Ahuja V, Amarchand R, Balamurugan R, Chowdhury SD, Daniel D, Das A, George G, Gupta SD, Krishnan A, Prasad JH, Kaur G, Pugazhendhi S, Pulimood A, Ramakrishna K, Verma AK. Prevalence of Adult Celiac Disease in India: Regional Variations and Associations. Am J Gastroenterol. 2016 Jan;111(1):115-23.PMID:26729543
23. Singla S, Kumar P, Singh P, Kaur G, Rohtagi A, Choudhury M. HLA profile of Celiac disease among First-degree relatives from a tertiary care center in North India. Ind j pediatr. 2016 Nov; 83(11):1248-1252.PMID:2726410124. Mishra A, Prakash S, Kaur G, Sreenivas V, Ahuja V, Gupta SD, Makharia GK. Prevalence of celiac disease among first-degree relatives of Indian celiac disease patients. Dig Liver Dis. 2016 Mar; 48(3):255-9.PMID:2669199225. Akinori Kimura, Daisuke Sakurai, Taeko Naruse, Hitoshi Ohtani, Gaurav Sharma, Surendra Sharma, Madhu Vajpayee, Narinder Mehra, and Gurvinder Kaur. APOBEC3H polymorphisms and susceptibility to HIV-1 infection in an Indian population. J Hum Genet. 2016 Mar; 61(3):263-5.
26. Jagadish N, Agarwal S, Gupta N, Fatima R, Devi S, Kumar V, Suri V, Kumar R, Suri V, Sadasukhi TC, Gupta A, Ansari AS, Lohiya NK, Suri A. Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer.J Exp Clin Cancer Res. 2016;35(1):150, PMID: 27658496
27. Jagadish N, Parashar D, Gupta N, Agarwal S, Suri V, Kumar R, Suri V, Sadasukhi TC, Gupta A, Ansari AS, Lohiya NK, Suri A. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.BMC Cancer. 2016; 16:561, PMID: 27473057.
28. Jagadish N, Parashar D, Gupta N, Agarwal S, Sharma A, Fatima R, Suri V, Kumar R, Gupta A, Lohiya NK, Suri A. A novel cancer testis antigen target A-kinase anchor protein (AKAP4) for the early diagnosis and immunotherapy of colon cancer.Oncoimmunology. 2016; 5(2):e1078965, PMID: 27057472.
29. Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, Patekar MB, Sahoo RK, Malik PS, Sharma OD, Gupta R. Autologous stem cell transplantation for multiple myeloma: Long-term results. Natl Med J India. 2016;29(4):192-199. PMID: 28050994
30. Gupta R. Genomic Classification of Acute Myeloid Leukemia- An Incessantly Evolving Concept. Natl Med J India2016;29(5):283-285 PMID:28098084
31. Sharawat SK, Raina V, Kumar L, Sharma A, Bakhshi R, Vishnubhatla S, Gupta R, Bakhshi S. High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in FLT3 internal tandem duplication (ITD) negative patients in adult acute myeloid leukaemia: A prospective pilot study from India. Indian J Med Res. 2016; 143(Supplement):S11-S16. PMID: 27748272.
32. Baghmar S, Kumar L, Rani L, Mathur N, Sreenivas V, Malik PS, Tilak TVSVGK, Gupta R. Prognostic Relevance of T Regulatory Cells in Patients with advanced-Stage Serous Carcinoma Ovary. Indian J Gynecol Oncolog 2016; 14:20.
33. Gupta R, Chandgothia M, Dahiya M, Bakhshi S, Sharma A, Kumar L. Multi-Drug Resistance Protein 1 as Prognostic Biomarker in Clinical Practice for Acute Myeloid Leukemia. Int J Lab Hematol. 2016; 38(5):e93-97 PMID: 27321806.
34. Rani L, Mathur N, Gogia A, Vishnubhatla S, Kumar L, Sharma A, Dubey D, Kaur P, Gupta R. Immunoglobulin Heavy Chain Variable Region Gene Repertoire and B-Cell Receptor Stereotypes in Indian Patients with Chronic Lymphocytic Leukemia.Leuk Lymphoma. 2016; 57(10):2389-2400, PMID: 26942309.
35. Nataraj V, Mathur N, Rani L, Gupta R, Bakhshi S. Serial assessment of circulating T regulatory cells and T helper 17 cells in pediatric non-Hodgkin lymphoma: a prospective study. LeukLymphoma. 2016;57(7):1739-42 PMID:26690272
36. Nataraj V, Tiwari A, Mathur N, Rani L, Gupta R, Mallick S, Sharma MC, Bakhshi S. Vascular endothelial growth factor expression in pediatric non-Hodgkin lymphoma: A prospective study. PediatrHematoOncol. 2016; 33(3):168-70 PMID: 27184774.
37. Chharchhodawala T, Gajendra S, Tiwari P, Gogia A, Gupta R. Therapy related acute myeloid leukemia with t(8;16) mimicking acute promyelocytic leukemia. Indian J Hematol Blood Transfus. 2016; 32:20-22 PMID: 27408347.
38. Sharma S, Arif M, Nirala RK, Gupta R, Thakur SC. Cumulative therapeutic effects of phytochemicals in Arnica montana flower extract alleviated collagen-induced arthritis: inhibition of both pro-inflammatory mediators and oxidative stress. J Sci Food Agric. 2016; 96(5):1500-1510. PMID: 25966322.
39. Gupta SK, Bakhshi S, Kumar L, Seth R, Kumar R. IKZF1 (IKAROS) deletions in B-ALL and its clinical correlation: A prospective study from a tertiary care centre in Northern India. Leukemia Research 2016; 41:7-11, PMID: 26704074.
40. Arora P, Gupta SK, Mallik N, Mittal R, Sharma OD, Kumar L. Flow cytometry in diagnosis of myelomatous pleural effusion: A Case Report 2016;32(Suppl 1):138-42, PMID: 27408376.
41. Seth R, Pathak N, Singh A, Chopra A, Kumar R, Kalaivani M. Pediatric Acute Myeloid Leukemia: Improved Survival Rates in India. Indian J Pediatr. 2017; 84(2):166-167, PMID: 27830523.
42. Chopra A, Soni S, Pati H, Kumar D, Diwedi R, Verma D, Vishwakama G, Bakhshi S, Kumar S, Gogia A, Kumar R. Nucleophosmin mutation analysis in acute myeloid leukaemia: Immunohistochemistry as a surrogate for molecular techniques. Indian J Med Res. 2016; 143(6):763-768, PMID:27748301.
43. Anand M, Hazarika B, Kumar L, Kumar R, Chopra A. High abundance of circulating megakaryocytic cells in chronic myeloid leukemia in Indian patients. Revisiting George Minot to re-interpret megakaryocytic maturation. Blood Cells Mol Dis. 2016; 60:28-32. Blood Cells Mol Dis. 2016; 62:64-66, PMID: 27519941.
44. Khunger JM, Chopra A, Arora S, Pati HP. Reconfirming HPLC-Detected Abnormal Haemoglobins by a Second Independent Technique: A Judicious Approach. Indian J Hematol Blood Transfus. 2016; 32(Suppl 1):304-6, PMID: 27408419.
45. Misra A, Soni S, Dutta A, Bakhshi S, Kumar R, Chopra A. APL-The Age-Old Harlequin: Do We See it All? Indian J Hematol Blood Transfus. 2016; 32(Suppl 1):78-9, PMID: 27408361.
46. Misra A, Mishra J, Chandramohan J, Sharma A, Raina V, Kumar R, Soni S, Chopra A. Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma. Indian J Hematol Blood Transfus. 2016; 32(1):10-7, PMID: 26855502.
47. Misra A, Verma D, Chandramohan J, Bakhshi S, Kumar R, Gajendra S, Chopra A. Nuclear cupping in the blasts-more to the cup than myeloid. Hematol Oncol. 2016; 34(3):171-3, PMID: 25370525.
48. Gajendra S, Chopra A, Kumar R. β-hCG-Secreting Anaplastic Large Cell Lymphoma.Turk J Haematol. 2015, PMID: 25913722.
49. Shah B, Gajendra S, Gupta R, Sharma A. Novel Cytogenetic aberrations in a patient of chronic myeloid leukemia with blast crisis. J ClinDiagn Res 2015; 9(5):XD05-XD06, PMID: 26155548.
50. Das A, Singh A, Gajendra S, Gupta R, Sazawal S, Seth R. An unusual case of phenotype switch between AML FAB subtypes. Clin Case Rep. 2015; 3(2):118-20. PMID: 25767711.
51. Bahl A, Sharma A, Raina V, Kumar L, Bakhshi S, Gupta R, Kumar R. Long-term outcomes for patients with acute myeloid leukemia: A single-center experience from AIIMS, India.Asia Pac J ClinOncol. 2015; 11: 242-252 PMID: 25639656.
52. Gupta SK, Chopra A, Singh S, Kumar R, Bakhshi S, Kumar L, Sharma A. Absence of CD9 expression in acute myeloid leukemia: possible correlation with t(8;21). Int J Lab Hematol. 2015; 37(3): e56-8
53. Gupta SK, Chandramohan J, Kumar L. AML transformation after autologous stem cell transplant for multiple myeloma. BMJ Case Rep. 2015; pii: bcr2015210024. PMID: 26025976
54. Gupta SK, Dass J, Saxena R. A rare case of double heterozygous state for HbD and HbE. Indian J Pathol Microbiol 2015; 58(1): 126-127PMID: 25673618.
55. Chopra A, Soni S, Verma D, Kumar D, Dwivedi R, Vishwanathan A, Vishwakama G, Bakhshi S, Seth R, Gogia A, Kumar L, Kumar R. Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases. Asia Pac J Clin Oncol. 2015;11(4):293-8, PMID: 26264145
56. Mallik N, Chopra A, Jha A, Gogia A, Kumar R. Development of myelodysplastic syndrome in a patient with chronic myelogenous leukemia treated with imatinib. Leuk Lymphoma. 2015; 56(4):1143-4,PMID: 25093381.
57. Mittal R, Chopra A, Soni S, Bakhshi S, Kumar R. "Tear drops" in the cerebrospinal fluid: correct by scatter, but pathognomonic by site. Cytometry B Clin Cytom. 2015; 88(3):204-6, PMID: 25257969.
58. Tanwar P, Kumar R. Dr APJ Abdul Kalam-“A Man beyond Science”. Journal of Clinical and Diagnostic research; 2015; 9(8); 1, PMID: 26435968.
59. Ranjan A, Sethi D; Spectrum of Lesions of Liver in Autopsy in India: One Year Study; IJCP, Vol. 26, No. 5, Oct 2015, p.461-63.
60. Kshitiz K K, Varun SK, Ranjan A, Kesari JR; Study of serum malondialdehyde and vitamin c status in type 2 diabetes mellitus, Int.J.Curr. Res. Aca.Rev. 2015, 3 (4): 20-25
61. Kumar N, Kaur G, Kanga U, Mehra NK, Neolia SC, Tandon N, Zucman SC. CTLA4+49G allele associates with early onset of type 1 diabetes in North India. Int J Immunogenet. 2015 Dec; 42 (6) :445-52
62. Iqbal N, Sharma A, Raina V, Kumar L, Bakhshi S, Kumar R, Gajendra S. Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief Report.Indian J Hematol Blood Transfus. 2014;30(4):215-8, PMID: 25435716
63. Gogia A, Mehta P, Pramanik R, Kumar R. Isolated breast relapse mimicking breast cancer in elderly patient with acute lymphoblastic leukemia.Turk J Haematol. 2014;31(2):203-4.
64. Gogia A, Raina V, Gupta R, Gajendra S, Kumar L, Sharma A, Kumar R, Vishnubhatla S. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.Clin Lymphoma Myeloma Leuk. 2014; 14(6):514-7.
65. Agarwal S, Parashar D, Gupta N, Jagadish N, Thakar A, Suri V, Kumar R, Gupta A, Ansari AS, Lohiya NK, Suri A. Sperm associated antigen 9 (SPAG9) expression and humoral response in benign and malignant salivary gland tumors.Oncoimmunology. 2014;3(12):e974382,PMID: 25941602
66. Sharma S, Gupta R, Thakur SC. Attenuation of Collagen Induced Arthritis by Centellaasiatica Methanol Fraction via Modulation of Cytokines and Oxidative Stress. Biomed Environ Sci. 2014; 27(12): 926-938 PMID: 25484009
67. Gajendra S, Gogia, A, Das P, Gupta R, Tanwar P. Acute myeloid leukemia presenting as “Bowel Upset”- A case report. J ClinDiag Res. 2014; 8(7): FD09-10 PMID: 25177572
68. Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A, Pramanik R, Gupta R. Complete response after autologous stem cell transplant in multiple myeloma. Cancer Med. 2014; 3:939-46. PMID: 24777883
69. Tilak T, Sherawat S, Agarwala S, Gupta R, Vishnubhatla S, Bakhshi S. Circulating T-Regulatory Cells in Neuroblastoma: A Pilot Prospective Study. PediatrHematolOncol. 2014; 31(8):717-22. PMID:24684178
70. Gogia A, Raina V, Gupta R, Gajendra S, Kumar L, Sharma A, Kumar R, Vishnubhatla, S. Prognostic and predictive significance of Smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.Clin Lymphoma Myeloma Leuk. 2014; 14(6):514-7 PMID: 24656596
71. Sharawat SK, Bakhshi R, Vishnubhatla S, Gupta R, Bakhshi S. FLT3-ITD Mutation in Relation to FLT3 Expression in Pediatric AML: a Prospective Study from India. PediatrHematolOncol. 2014; 31(8):717-22 PMID: 24498869
72. Sharawat SK, Gupta R, Raina V,Kumar L, Sharma A, Iqbal S,Bakhshi R, Vishnubhatla S, Bakhshi S. Quantitative Assessment of BAX Transcript and Flow-cytometric Expression in Acute Myeloid Leukemia: a prospective study FLT3-ITD. Hematology 2014;19(7):404-11 PMID: 24620954
73. TilakTV, Sharawat SK, Gupta R, Agarwala S, Khan SA, Rastogi S, Sreenivas V, BakhshiS.Circulating T- regulatory cells in PNET: A prospective study. Pediatr Blood Cancer 2014;61:228-232 PMID: 23997029
74. Gajendra S, Gogia A, Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, Gupta R. Synchronous metastatic pulmonary adenocarcinoma with small cell lymphoma. Leuk Lymphoma 2014; 55: 1678-1680. PMID: 24073807
75. Gogia A, Mehta P, Pramanik R, Gupta R. Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation. South Asian J Cancer. 2014;3(4):235-6 PMID: 25422818
76. Gajendra S, Gupta R, Chandgothia M, Kumar L, Gupta R, Chavan SM. Chronic Neutrophilic Leukemia with V617F JAK2 Mutation. Indian J Hematol Blood Transfus2014;30(2):139-42 PMID: 24839370
77. Kaur G. Risk of Pediatric Celiac Disease according to HLA haplotype and Country: Immunogeneticist’s viewpoint. Indian Pediatr. 2014 Sep 8; 51(9):736-7. PMID:24988556
78. Mehra NK, Kumar N, Kaur G. Hematopoietic stem cell transplantation: HLA matching requirements for donor selection Thalacemics India Newsletter. 2014
79. Kumar N, , Kaur G, Kanga U, Tandon N, Caillat-Zucman S, Mehra NK.Association of PTPN22+1858C/T polymorphism with type 1 diabetes in the North Indian population. Int J Immunogenet. 2014 Jun 10. doi: 10.1111/iji.12129.
80. Mishra G, Kumar N, Kaur G, Jain S, Tiwari PK, Mehra NK.Distribution of HLA-A,B and DRB1 alleles in Sahariya tribe of North Central India: an association with pulmonary tuberculosis. Infect Genet Evol. 2014 Mar;22:175-82
81. Gupta SK, Kumar R, Chharchhodawala T, Kumar L. Secondary pure erythroid leukaemia in relapsed acute lymphoblastic leukaemia: lineage switch or chemotherapy effect? BMJ Case Rep. 2014 May 19;2014. pii: bcr2013201724. doi: 10.1136/bcr-2013-201724, PMID: 24842350
82. Chopra A, Bakhshi S, Pramanik SK, Pandey RM, Singh S, Gajendra S, Gogia A, Chandramohan J, Sharma A, Kumar L, Seth R, Rai S, Kumar R. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL. Eur J Haematol. 2014;92(3):211-8, PMID: 24329989
83. Gajendra S, Das RR, Chopra A, Singh A, Seth R. Accelerated phase at initial presentation in Chédiak-Higashi syndrome: is it really uncommon ? Pediatr Hematol Oncol. 2014;31(4):382-5
84. Ranjan A, Pramanik R, Gupta R, Tanwar P, Bharati S, Ray M, Chandoke R, Kumar A. Chronic Neutrophilic leukemia: A rare chronic myeloproliferative disorder. International Journal of Hematology and Oncology; 2014; 24; 145-147.
85. Ramnani BG, Kumar A, Chandak S, Ranjan A, Patel MK. Clinicopathological Profile of Benign Soft Tissue Tumours: A Study in a Tertiary Care Hospital in Western India; J. of Clin. & Diagn. Res. Oct 2014, Vol-8 (10): FC01-FC04, PMID: 25478344
86. Yadav R, Sharma MC, Karak AK, Agarwal N, Kumar R, Kumar L. Natural history of primary precursor B lymphoblastic lymphoma of the ovary: report of a rare case.J Obstet Gynaecol Res. 2013;39(2):611-6
87. Sahoo RK, Kumar L, Kumar R, Sharma A. Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics.Indian J Med Paediatr Oncol. 2013;34(4):327-9, PMID: 24604968.
88. Kanojia D, Garg M, Saini S, Agarwal S, Parashar D, Jagadish N, Seth A, Bhatnagar A, Gupta A, Kumar R, Lohiya NK, Suri A. Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma.PLoS One. 2013;8(12):e81348, PMID: 24349057.
89. Gogia A, Sharawat SK, Kumar R, Sarkar C, Bakhshi S. Systemic mastocytosis associated with childhood acute myeloid leukemia.J Pediatr Hematol Oncol. 2013;35(2):163-4, PMID: 22584780
90. Gajendra S, Gupta R, Gupta R, Kumar L. Coexistence of scleroderma with multiple myeloma: a rare association. BMJ Case Rep. 2013; Sep 10; 2013. doi:pii: bcr2013200639. 10.1136/bcr-2013-200639 PMID: 24022902
91. Ghosh J, Singh RKB, Saxena R, Gupta R, Vivekanandan S, Sreenivas V, Raina V, Sharma A, Kumar L. Prevalence and aetiology of anaemia in lymphoid malignancies. Natl Med J India 2013; 26: 79-81 PMID:24093980
92. Sharawat SK, Gupta R, Raina V, Kumar L, Sharma A, Iqbal S,Bakhshi R, Vishnubhatla S, Bakhshi S. Increased co-expression of c-KIT and FLT-3 receptors on myeloblasts: independent predictor of poor outcome in pediatric acute myeloid leukemia.Clinical Cytometry2013; 84(6): 390-397 PMID: 23740774
93. Gogia A, Gupta R, Raina V. Disseminated tuberculosis mimicking relapse in Hairy cell leukemia. Indian J Cancer 2013;50:321PMID:24369208
94. Gogia A, Raina V, Gupta R. Massive ascites as apresenting feature of Plasma Cell Leukemia. Indian J Cancer 2013;50:301, PMID:24369201
95. Gogia A, Sharma A, Raina V, Kumar L, Gupta R, Kumar R. Prevalence of ZAP70 and CD38 in Indian chronic lymphocytic leukemia patients.Indian J Cancer 2013;50(4):333-336, PMID:24369212.
96. Sharawat SK, Bakhshi R, Vishnubhatla S, Gupta R, Bakhshi S. BAX/BCL2 RMFI ratio predicts better induction response in pediatric patients with acute myeloid leukemia. Pediatr Blood Cancer. 2013; 60:E63-6 PMID: 23553948
97. Bhaskar A, Gupta R, Sreenivas V, Rani L, Kumar L, Sharma A, Sharma OD, Sharma MC, Thakur SC. Synergistic effect of vascular endothelial growth factor and angiopoietin-2 on progression free survival in multiple myeloma. Leuk Res. 2013; 37:410-415 PMID: 23332455
98. Baghmar S, Mohanti BK, Sharma A, Kumar L, Prakash G, Kumar S, Gupta R, Kumar R, Raina V. Solitary Plasmacytoma: 10 years’ experience at AIIMS, New Delhi. Leuk Lymphoma. 2013; 54:1665-1670. PMID: 23163525
99. Bhaskar A, Gupta R, Sreenivas V, Kumar L, Sharma A, Sharma MC, Prasenjit Das P, Thakur SC. Angiopoietins as biomarker of disease activity and response to therapy in multiple myeloma. Leuk Lymphoma. 2013; 54:1473-8 PMID: 23113684
100. Desai PA, Dholariya S, Gupta S, Singh T. Plasma cell leukemia of IgG secreting type: A rare case. Int J Case Rep Images 2013; 4(12):748–9.
101. Kapoor R, Pati HP, Gupta SK, Gupta N. Acute Promyelocytic Leukemia Presenting as Ischemic Stroke in Young. Indian J Hematol Blood Transfus; 2013;29(2):93-5, PMID: 24426346
102. Gogia A, Sharma A, Chopra A, Kumar R. Mediastinal granulocytic sarcoma: poor risk AML? J Indian Med Assoc. 2013;111(8):562, PMID: 24783400
103. Soni S, Wadhwa N, Kumar R, Faridi MM, Sharma S, Chopra A, Singh S. Evaluation of CD64 expression on neutrophils as an early indicator of neonatal sepsis. Pediatr Infect Dis J. 2013;32(1):e33-7.PMID: 22914559
104. Seth R, Bolia R, Jain R, Chopra A, Singh S, Kumar R. Superior mediastinal syndrome : a rare presenting feature of acute myeloid leukemia. Indian J Pediatr. 2013;80(2):165-7, PMID: 22674250
105. Shashikant CU Patne, Pradhan S, Mittal R, Kumar M, Tanwar P. Glottic Squamous Cell Carcinoma Metastatic to the Brain. Asian Journal of medical sciences; 2013; 5(1); 77-80
106. Ranjan A, RK Chandoke, Tanwar P, Kumar A, MD Ray, KK Kshitiz, Chauhan N. Myeloid Sarcoma of Maxillo-Ethmoidal Sinus: An Uncommon Presentation of Acute Myeloid Leukemia. Indian Journal of Clinical Practice; 2013; 24(5); 442-445.
107. Tanwar P, Kumar AS, Chhabra S. Civatte bodies: a diagnostic clue. Indian J Dermatol; 2013; 58(4): 327-30, PMID: 23919028
108. Kumar M, Tanwar P, Radhika S, Dey P. Fine needle aspiration cytology of primary mucormycosis of the breast in a young immunocompetent pregnant woman. Cytopathology; 2013; 24(6):411-2.
109. Ranjan A, Chandoke RK, Chauhan N, Kumari R, Study of Tumors by Imprint Cytology, IJCP, Vol. 24, No. 5, October 2013, p.472-76
110. Chopra A, Kumar R, Kishore K, Tandon N, Yusuf T, Kumar S, Mishra P, Saxena R. Effect of glucocorticoids on von Willebrand factor levels and its correlation with von Willebrand factor gene promoter polymorphism.Blood Coagul Fibrinolysis. 2012; 23(6):514-9PMID:22688555
111. Chopra A, Pati H, Mahapatra M, Mishra P, Seth T, Kumar S, Singh S, Pandey S, Kumar R. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.Ann Hematol. 2012;91(9):1351-62, PMID: 22526362
112. Mishra J, Chopra A, Gogia A, Kumar R. Seemingly insignificant, but crucial morphological leads in the diagnosis of non-secretory multiple myeloma in an adolescent.Indian J Pathol Microbiol. 2012;55(1):130-2, PMID: 22499328
113. Soni S, Wadhwa N, Kumar R, Faridi MM. Use of immature-to-total-neutrophil ratio in early neonatal sepsis.Pediatr Infect Dis J. 2012;31(10):1101-2, PMID: 22982953
114. Sharma A, Bahl A, Raina V, Kumar L, Gupta R. Dasatinib in chronic myeloid leukemia: A limited Indian experience. Asia-Pacific Journal of Clinical Oncology. 2012; 8:375-9 PMID: 22897916
115. Gogia A, Sharma A, Raina V, Kumar L, Vishnubhatla S, Gupta R, Kumar R. Assessment of 285 cases of CLL seen at single large tertiary centre from Northern India. Leuk Lymphoma. 2012;53(10):1961-5. PMID:22475243
116. Gogia A, Sharma A, Raina V, Gupta R. Priapism as an initial presentation of chronic lymphocytic leukemia. Leuk Lymphoma. 2012;53:1638-9 PMID:22242818
117. Bhaskar A, Gupta R, Kumar L, Sharma A, Sharma MC, Kalaivani M, Thakur SC. Circulating endothelial progenitor cells as potential prognostic biomarker in multiple myeloma. Leuk Lymphoma. 2012; 53:635-40. PMID: 21973309
118. Naseem S, Kaur S, Gupta R, Kashyap R, Nityanand S. Plasma Cell Leukemia: Case Series From a Tertiary Center with Review of Literature. Ind J Hematol Blood Transfus. 2012; 28:10-14 PMID:23449039
119. Aggarwal S, Alam S, Khanna R, Maras JS, Gupta SK, Ahuja A. Novel nonsense mutation of ABHD5 in Dorfman Chanarin syndrome with unusual findings: A challenge for genotype-phenotype correlation. Eur J Med Genet 2012; 55(3): 173-7, PMID: 22373837
120. Sharma SK, Gupta S, Seth T, Mishra P, Mahapatra M, Singh MK, Gupta S. Leukemia Cutis: An Unusual Presentation. Indian J Hematol Blood Transfus, 2012; 28(3): 175-177, PMID: 23997455.
121. Khera R, Gautam P, Gupta S, Arora P, Singh T, Gupta N. Adult T Lymphoblastic Leukemia (Pro-T ALL) with Reactive Monocytosis: A Case Report. Indian J Hematol Blood Transfus; 2014;30(1):29-33, PMID: 24554818
122. Tyagi R, Kumar M, Tanwar P, Dey P. Mucinous carcinoma of breast: FNAC as effective diagnostic modality. Asian Journal of medical sciences; 2012; 3, (3); 32-35.
123. Tanwar P, Gupta N, Vasishta RK, Singh G. Fine needle aspiration cytology in fibromatosis. Journal of Cytology; 2012; 29(1); 66-8